NCT04990414

Brief Summary

Case series design with participants with psychosis with a history of interpersonal trauma/abuse and current distressing auditory verbal hallucinations and dissociative experience. Participants were offered up to 24 therapy sessions over a 6-month intervention window.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for phase_2 schizophrenia

Timeline
Completed

Started Nov 2013

Longer than P75 for phase_2 schizophrenia

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 24, 2013

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2019

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

June 24, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 4, 2021

Completed
Last Updated

August 4, 2021

Status Verified

July 1, 2021

Enrollment Period

5.2 years

First QC Date

June 24, 2021

Last Update Submit

July 27, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in the Dissociative Experiences Scale - time bound

    Change in the frequency of dissociative experiences, assessed via a questionnaire measure assessing presence and frequency of dissociative experiences in the previous month

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

  • Change in the Psychotic Symptoms Rating Scale - auditory hallucinations subscale

    change in the severity of hallucinatory experiences, assessed via a clinical interview measuring for presence and severity of auditory hallucinations in the previous week

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

Secondary Outcomes (5)

  • Change in the Psychotic Symptoms Rating Scale - delusions subscale

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

  • Change in the Impact of Events Scale Revised

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

  • Change in the short Depression, Anxiety and Stress Scales

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

  • Change in the Questionnaire about the Process of Recovery

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

  • Change in the short-form of the CHoice of Outcome In Cbt for psychosEs (CHOICE)

    baseline, at mid-treatment (approximately 3 months after the baseline assessment), at the end of treatment (6 months after baseline), and again at 6 months following the end of treatment

Study Arms (1)

CBT for voices and dissociation

EXPERIMENTAL

24 sessions of Cognitive Behavioural Therapy (CBT) over a 6-month period treatment window.

Other: Cognitive Behavioural Therapy

Interventions

Sessions 1-4 were focused on engagement, assessment of presenting problems, identification of treatment goals and normalization/ psychoeducation. Sessions 5- 14, focused on techniques to manage dissociative responses and/or increase perceived controllability of dissociation. Although further work on dissociation and/or trauma was encouraged, the targets for intervention in subsequent sessions (15-22) and the strategies selected depended on individual formulation of clients' difficulties and negotiation with the client. This could include re-appraisals on negative beliefs about dissociative experiences, cognitive and/or behavioural change strategies targeting core appraisals of voices leading to related distress, trauma-related techniques (e.g., imagery techniques,), or consolidation of a developmental/longitudinal psychological formulation of the client's difficulties. The final two sessions focused on plans for relapse prevention and maintenance of gains.

CBT for voices and dissociation

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Be in contact with mental health services.
  • Have an identified care coordinator.
  • Meet ICD-10 criteria for schizophrenia, schizoaffective disorder or delusional disorder or meet entry criteria for an Early Intervention in Psychosis service in order to allow for diagnostic uncertainty in early phases of psychosis.
  • History of voice-hearing for a minimum of six months.
  • Aged 16 and above.
  • Score ≥ 2 (i.e. "Voices occurring at least once a day") on the frequency item of the PSYRATS.
  • Score ≥ 3 (i.e. "Voices are very distressing, although subject could feel worse") on the distress intensity rating of the PSYRATS.
  • Confirmed that they consider AVHs, dissociative experiences, and/or trauma as their main problem or presenting difficulty, and that would like to receive a psychological intervention specifically designed to address these difficulties - this will be assessed using four items integrated in the PSYRATS interview administered as part of the present study, and the self-reported therapy goals generated through the CHOICE short form.
  • Score ≥ 1 on any of the items of the Bref Betrayal Trauma Survey assessing lifetime exposure to interpersonal trauma (i.e. items 3-11).
  • scores suggestive of clinical levels of dissociative symptoms, as indicated by a score \> 20 on the Dissociative Experiences Scale, time bound
  • Capacity to provide informed consent.
  • Judged by their clinician to be clinically stable for the preceding 4 weeks

You may not qualify if:

  • Any person without capacity to provide written informed consent.
  • If the experience of voices/psychosis is organic in origin (for example, hallucinatory experiences linked to traumatic brain injuries, organic psychoses, or emerging in the context of dementing conditions).
  • Insufficient command of English to complete the research interviews and measures.
  • Intellectual disability, or severe cognitive dysfunction that might preclude the individual's ability to provide informed consent, understand the study procedure and/or fully appreciate the potential consequences of their participation.
  • Primary diagnosis of substance misuse dependency.
  • Where care coordinators identify reasons for why participation might be potentially detrimental.
  • Inpatient/acute care needed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Varese F, Douglas M, Dudley R, Bowe S, Christodoulides T, Common S, Grace T, Lumley V, McCartney L, Pace S, Reeves T, Morrison AP, Turkington D. Targeting dissociation using cognitive behavioural therapy in voice hearers with psychosis and a history of interpersonal trauma: A case series. Psychol Psychother. 2021 Jun;94(2):247-265. doi: 10.1111/papt.12304. Epub 2020 Sep 10.

MeSH Terms

Conditions

SchizophreniaPsychological TraumaDissociative DisordersHallucinations

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersStress Disorders, TraumaticTrauma and Stressor Related DisordersPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Case series
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Clinical Lecturer

Study Record Dates

First Submitted

June 24, 2021

First Posted

August 4, 2021

Study Start

November 24, 2013

Primary Completion

January 29, 2019

Study Completion

January 29, 2019

Last Updated

August 4, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share